BCM
YTEN

Bridgeway Capital Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Bridgeway Capital Management’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3
Closed -$201K – 1451
2013
Q3 		$201K Hold
3
– – 0.01% 1315
2013
Q2 		$227K Buy
+3
New +$290K 0.01% 1241

Other funds holding YTEN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bridgeway Capital Management's YTEN Position: Q4 2013 in Review

Bridgeway Capital Management sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q4 2013, closing a stake of 3 shares — an estimated $201K sold.

Bridgeway Capital Management first reported a position in YTEN in Q2 2013 and held it in 2 quarters. The position peaked at $227K in Q2 2013. 13 funds tracked by Wall St. Rank hold YTEN as of Q4 2013.

  • Bridgeway Capital Management reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • Bridgeway Capital Management sold 3 Yield10 Bioscience, Inc. Common Stock shares in Q4 2013, an estimated $201K.
  • Bridgeway Capital Management first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 2 quarters.
  • Bridgeway Capital Management's Yield10 Bioscience, Inc. Common Stock position peaked at $227K in Q2 2013.
  • 13 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q4 2013.

Based on Bridgeway Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.